Scion /
BioLargo
Scion to receive SkinDisc IP from BioLargo
- Terms
- Not stated
- Stage
- Agreement signed
What happened
BioLargo and Clyra Medical agreed to transfer the Scion IP back to Scion under an agreement fully executed on March 3, 2022.
In exchange, Scion agreed to accept 2,000,000 BioLargo common shares, forgive the outstanding principal and interest on the Scion Promissory Note, and return its Clyra common stock.
The source
Everything on this page comes from the source below.
Scion to receive SkinDisc IP from BioLargo
This document is the source for the companies, stage and people on this page.
Original filingUnlock with ProTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Agreement signed
The source this page is built from.
Published by the source
The source this page is built from.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request accessAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly